Linagliptin as add-on treatment to glimepiride in patients with HNF1A-diabetes (MODY3): a randomised, double-blinded, placebo-controlled, crossover trial
title = "Linagliptin as add-on treatment to glimepiride in patients with HNF1A-diabetes (MODY3): a randomised, double-blinded, placebo-controlled, crossover trial",
author = "Christensen, \{A. S.\} and S. Haedersdal and J. Stoy and H. Storgaard and U. Kampmann and M. Seghieri and Holst, \{J. J.\} and T. Hansen and Knop, \{F. K.\} and T. Vilsboll",
year = "2020",
month = sep,
language = "English",
pages = "S78--S79",
}
TY - ABST
T1 - Linagliptin as add-on treatment to glimepiride in patients with HNF1A-diabetes (MODY3): a randomised, double-blinded, placebo-controlled, crossover trial